Closing the gap between suspecting a heart attack and confirming it
A person having a heart attack may be only feet from medical care but miles from the laboratory testing needed to confirm it. That gap matters, especially for rural patients, those in nursing homes, ambulances and other places where access to specialized diagnostics is limited.
When a person experiences a heart attack, they may be within close proximity to medical assistance, yet miles away from the specialized laboratory tests required to confirm the severity of the condition. This delay becomes particularly critical for rural patients, nursing home residents, those in ambulances, and other locations where access to advanced diagnostic tools is restricted.
A recent study published in the journal Biosensors and Bioelectronics introduces a novel, highly sensitive test aimed at bridging this diagnostic gap.
Dr. Sayantan Tripathy, the lead author from Texas A&M University's Optical and Bio-Sensing Laboratory, emphasized that a heart attack does not wait for laboratory results. By shortening the time to detect heart muscle damage, clinicians can more swiftly move from uncertainty to decisive action, not just in hospitals but also in ambulances and resource-limited settings.
Clinicians often suspect a heart attack based on symptoms or electrocardiogram readings, but verifying heart muscle injury typically involves measuring cardiac troponin I—a protein released when the heart is injured. Traditional high-sensitivity tests commonly necessitate centralized laboratory equipment, which can introduce a dangerous delay between the initial suspicion and the confirmation of heart damage.
The researchers sought to develop a diagnostic tool that emergency medical technicians could use directly at the scene. Dr. Samuel Mabbott, an associate professor of biomedical engineering and co-author of the study, envisioned a system where a physician could collect a small blood sample—just a fingertip prick—place it in a cartridge containing all the necessary components, insert it into the device, and receive results within five minutes.
This approach addresses the longstanding issue where obtaining confirmation for a heart attack can take considerable time, especially in the absence of advanced laboratory resources.
The innovation relies on a specially engineered DNA molecule that becomes functional only when it interacts with cardiac troponin I. Upon detection, the DNA molecule initiates a chain of molecular reactions that amplify the signal, allowing for the precise detection of even minute levels of heart injury. This amplified signal is then measured using portable optical sensing technology.
Although the current version requires about 25 minutes for testing, the researchers are actively working to reduce this time to under 15 minutes, making the tool even more practical for immediate use.
While the technology is still in the development phase and needs additional refinement and clinical validation before it can be widely adopted in clinical practice, the study represents a significant step toward delivering life-saving diagnostic information closer to the patient. This advancement could ultimately lead to faster, more accurate decisions, ultimately improving patient outcomes.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
